Under5 Guidance

COVID-19 Vaccine Authorized and Recommended for Children Under 5

Jun 21, 2022 | Amiris Roberson, Program Analyst, Immunization

After successfully submitting data from their respective clinical trials, the Pfizer-BioNTech and Moderna COVID-19 vaccines have been authorized and recommended for Emergency Use (EUA) for our youngest population – 6 months through 4 years for Pfizer, and 6 months through 5 years for Moderna. The process entailed a thorough review of the available data from both vaccine manufacturers by the U.S Food and Drug Administration’s (FDA) Vaccines and Related Biological Products Advisory Committee (VRBPAC), the Advisory Committee on Immunization Practices (ACIP) and the Centers for Disease Control and Infection (CDC) Director. The authorization of this vaccine, and the eventual vaccination of our youngest population, brings us closer to protecting them from COVID-19.

The Pfizer-BioNTech vaccine has been approved for use in children aged 6 months to 4 years. It is a three-dose series with three weeks between the first two doses and eight weeks between doses two and three. The Moderna vaccine has been approved for children 6 months to 5 years and is a two-dose series, with the doses four weeks apart.

Local Health Departments will again play a vital role in the vaccination of this population. The CDC has updated their COVID-19 Pediatric Planning Guide which highlights important considerations in preparing to administer and distribute these vaccines. Additional considerations include:

Equity in Childhood COVID-19 Vaccination: COVID-19 vaccine equity is when all people who are eligible, including children, have fair and just access to COVID-19 vaccination. However, there are children that face barriers to vaccination, including those who are experiencing homelessness, racial and ethnic minority groups, and/or those with developmental disabilities. Local health departments will play a significant role in ensuring equitable vaccine rollout.

Partners for Childhood COVID-19 Vaccination: Communities can partner with local providers to administer the COVID-19 vaccines to children to ensure access to the vaccines. These partners may include pediatricians, pharmacies, community clinics, schools and school districts, early education centers and community organizations. Local Health Departments will play a significant role in ensuring that these partnerships occur.

CDC and others have released several additional resources to assist with planning for administering pediatric vaccines, including:

CDC will also be hosting an All-State, Tribal, Local, and Territorial (STLT) Update Call on Tuesday, June 21st to provide information and updates on the approval of these vaccines. Register for the call here.


About Amiris Roberson, Program Analyst, Immunization

More posts by Amiris Roberson, Program Analyst, Immunization

Related Posts

NACCHO color pms321
  • Press Release
  • Access to Care
  • Health Equity & Social Justice
  • Maternal, Child, & Adolescent Health

NACCHO Statement on U.S. Supreme Court Decision on Dobbs...

Today, the U.S. Supreme Court announced its decision on Dobbs v. Jackson...

Jun 24, 2022 | Adriane Casalotti

NACCHO Statement on U.S. Supreme Court Decision on Dobbs...

Cdc hiv nhtd 2022 promo english square
  • HIV, STI, & Viral Hepatitis

Dear Colleague: National HIV Testing Day

A new Dear Colleague letter from the CDC’s Division of HIV Prevention discusses...

Jun 24, 2022 | Guest Author, Julia Zigman

Dear Colleague: National HIV Testing Day

  • Tools & Resources
  • Climate Change
  • Health & Disability

Preparing People with Disabilities for Climate Change:...

Learn why having the voices of people with disabilities directly at the table...

Jun 23, 2022 | Guest Author

Preparing People with Disabilities for Climate Change:...

Cdc hiv nhtd 2022 promo english square
  • HIV, STI, & Viral Hepatitis

HIV Testing is Self-Care: National HIV Testing Day is...

Join health department, federal, and community partners across the U.S. in...

Jun 17, 2022 | Julia Zigman

HIV Testing is Self-Care: National HIV Testing Day is...

MRC Logo
  • Press Release

NACCHO Announces $9.5 Million in Awards to Local Medical...

Largest awards to date will strengthen MRC Network’s ability to deploy a ready,...

Jun 14, 2022 | Beth Hess

NACCHO Announces $9.5 Million in Awards to Local Medical...

Injection
  • Press Release

NACCHO Awards $300,000 in Funding to Local Health...

The National Association of County and City Health Officials (NACCHO), the...

Jun 09, 2022 | Nicholas Holmes

NACCHO Awards $300,000 in Funding to Local Health...

Baby formula
  • Tools & Resources
  • Maternal, Child, & Adolescent Health

NACCHO Responds to Current National Infant Formula...

NACCHO is continuing to closely monitor the infant formula shortage that is...

Jun 08, 2022 | Elana Filipos

NACCHO Responds to Current National Infant Formula...

Adult vaccinations sm
  • COVID-19
  • Funding Opportunity
  • Health Equity & Social Justice
  • Immunization

Request for Applications: Partnering for Vaccine Equity

NACCHO, with support from the Centers for Disease Control and Prevention (CDC),...

Jun 07, 2022 | Victoria Thompson, Katherine Waters

Request for Applications: Partnering for Vaccine Equity

DPS
  • Health & Disability
  • Policy

Reflections on Disability Policy Seminar 2022: A...

The 2021-2022 NACCHO Health & Disability fellows had the opportunity to travel...

Jun 01, 2022 | Guest Author

Reflections on Disability Policy Seminar 2022: A...

Back to Top